Qurgen

About:

Qurgen focuses on the development of efficient protein in vitro and in vivo Cell and tissue reprogramming technology.

Description:

Qurgen is a biotechnology company that focuses on the development of efficient protein in vitro and in vivo Cell and tissue reprogramming technology. It features the breakthrough protein targeted transport and efficient in vitro and in vivo protein-induced stem cells and other patented technologies. The company was founded in 2016 and headquartered in Iowa, United States.

Total Funding Amount:

$9.75M

Headquarters Location:

Troy Mills, Iowa, United States

Founded Date:

2016-01-01

Founders:

Feng Jiang, Michael Chopp

Number of Employees:

1-10

Last Funding Date:

2018-02-13

IPO Status:

Private

Industries: